Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000321332 | SCV000333018 | uncertain significance | not provided | 2015-07-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000537162 | SCV000642721 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765585 | SCV000896900 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000321332 | SCV000971411 | likely benign | not provided | 2018-06-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Mayo Clinic Laboratories, |
RCV000321332 | SCV002541979 | uncertain significance | not provided | 2021-11-17 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000321332 | SCV003824760 | uncertain significance | not provided | 2022-09-06 | criteria provided, single submitter | clinical testing |